SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-99-001025
Filing Date
1999-03-30
Accepted
1999-03-30 00:00:00
Documents
11
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 225846
2 AMENDMENT TO AMENDED AND RESTATED BY-LAWS EX-3.02B 7967
3 AMENDMENT TO 1998 OPTION PLAN EX-10.01D 480
4 AMENDMENTS TO SNYDER CONSULTING AGREEMENT EX-10.15D 9381
5 AMENDED AND RESTATED LICENSE AGREEMENT EX-10.16C 70617
6 AMENDMENTS TO DIRECTORS' STOCK OPTION PLAN EX-10.19B 12461
7 AMEND. TO FORM OF DIRECTORS' STOCK OPTION AGRMNT EX-10.19C 12905
8 PORTIONS OF 1998 ANNUAL REPORT TO STOCKHOLDERS EX-13.01 157323
9 SUBSIDIARIES OF THE REGISTRANT EX-21.01 523
10 CONSENT OF KPMG LLP EX-23.01 1042
11 FINANCIAL DATA SCHEDULE EX-27.01 2449
  Complete submission text file 0000950133-99-001025.txt   503448
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 99578282
SIC: 2834 Pharmaceutical Preparations